
AHA's 2026 Dyslipidemia Guideline: Start Screening Early for Lifelong Heart Health
The AHA and ACC released the 2026 Guideline on the Management of Dyslipidemia, shifting from older risk scores to the PREVENT-ASCVD calculator to estimate 10- and 30-year ASCVD risk and emphasize lifelong heart-risk reduction through earlier screening and personalized therapy. It highlights measuring biomarkers like Lp(a) and ApoB, using coronary artery calcium scoring, and keeping statins as first-line therapy with new lipid-lowering options, advocating for earlier intervention—especially in younger adults—to reduce future heart attack and stroke risk.


